# DalCor Pharmaceuticals

**Canonical:** https://apis.io/providers/dalcor-pharmaceuticals/  
**Website:** https://dalcorpharma.com/  
**APIs profiled:** 7

DalCor Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2015 and headquartered in Montreal, Quebec, with offices in Zug, Switzerland, Leatherhead in the United Kingdom, and Sarasota, Florida. It is developing dalcetrapib, positioned as the first pharmacogenetic precision medicine in cardiovascular disease, targeted specifically at patients carrying the AA genotype at the rs1967309 variant of the ADCY9 gene — a genotype present in up to 20% of the general population and in more than 40% of populations of African ancestry. DalCor holds the worldwide exclusive license to develop, manufacture and commercialise dalcetrapib together with rights to the companion genetic marker. The compound is being evaluated in Dal-GenE-2 (DAL-302), a Phase 3 double-blind randomized placebo-controlled cardiovascular outcomes confirmatory trial in 2,000 post-acute-coronary-syndrome patients with the ADCY9 AA genotype, coordinated by the Montreal Health Innovations Coordinating Centre and following the dal-GenE (DAL-301) trial, which showed a 21% relative risk reduction in fatal and non-fatal myocardial infarction across 6,149 patients in 34 countries. DalCor runs no developer program and publishes no product API; the only machine-readable surface it exposes is the anonymously readable WordPress REST content API behind dalcorpharma.com, which serves the bilingual English/French corporate site.

## Kin Score — 29.2 / 100 (thin)

Scored 2026-08-12 under rubric 0.11.0. Trend: flat (+0.0 from 29.2).

| Facet | Score |
|---|---|
| Discoverability | 81.5 |
| Contract Quality | 59.1 |
| Governance | 11.5 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 16.8 |
| Commercial Clarity | 10.5 |

Regulatory layer — **Health**: 26.3 (matched via tags).

## Agent readiness — 33.1 (agent-aware)

| Dimension | Value |
|---|---|
| Spec Presence | yes |
| Agentic Access | no |
| MCP Server | no |
| Auth Clarity | yes |
| Idempotency | no |
| Error Semantics | documented |
| OpenAPI Examples | partial |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | derived |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## APIs (7)

- **DalCor Pharmaceuticals Categories API** — Post categories
- **DalCor Pharmaceuticals Comments API** — Comments on posts (collection is empty on this site)
- **DalCor Pharmaceuticals Discovery API** — Site index, namespace route index, content types, taxonomies and statuses
- **DalCor Pharmaceuticals Media API** — Media library items (logos, poster PDFs/JPEGs, trial imagery)
- **DalCor Pharmaceuticals Pages API** — Corporate, science and clinical-trial pages
- **DalCor Pharmaceuticals Posts API** — DalCor press releases and corporate news
- **DalCor Pharmaceuticals Search API** — Cross-content search

## Security (2)

- **Dalcor Pharmaceuticals Authentication** — http · 1 scheme
- **Dalcor Pharmaceuticals Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, pharmaceuticals, biotechnology, cardiovascular, precision-medicine, pharmacogenomics, clinical-trials, life-sciences, content-api

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/dalcor-pharmaceuticals/). Scores are computed from the provider's own public artifacts under a published rubric.